Cardinal Health opens Advanced Therapy Innovation Center in La Vergne, Tennessee
New space supports advanced therapy solutions capabilities and dedication to life-saving treatments.
New space supports advanced therapy solutions capabilities and dedication to life-saving treatments.
The National Community Pharmacists Association announced the featured presenters for its 2024 Annual Convention, set for Oct. 26-29 in Columbus, Ohio.
The discussions with staff centered around PBM reform.
Collaboration brings ionnovative neighborhood pharmacy benefits to communities nationwide.
Year to date, major U.S. retailers have announced 4.0% more openings and 48.2% more closures when compared to the same time last year.
Brand aims to continue empowering consumers to celebrate their beauty with confidence.
Individuals can schedule COVID-19 vaccination appointments at Walgreens pharmacies nationwide within 24 hours, with availability beginning September 6 and inventory arriving in the coming days.
Consumers look for deals and shop around to deal with inflation's impact on food prices
The approval is based on the full body of previous clinical, non-clinical, and real-world evidence supporting the safety and effectiveness of the COVID-19 vaccines by Pfizer and BioNTech.
The chain expects to open appointments to administer the 2024-2025 seasonal COVID-19 vaccine early next week.
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Shelf-stable shoppers claim to be less brand loyal and more willing to switch, but in reality, they only purchase an average of 1.5% of the brands that are available to them.
Football Mix features HARIBO's chewy and pillowy textures in double-layered shapes that are iconic to the sport.
The Prabal Gurung x KISS collection offers six unique nail designs in a variety of the trendiest lengths and shapes, offering luxurious, fashion-forward looks in the form of an at-home manicure.
The Biosimilar Council appreciates and agrees with the FDA's position that data from a switching study or studies may no longer be necessary to support licensure of interchangeable biosimilar medicines.